Freddy Van Goethem
- Cancer Research top 10%
- Molecular Biology
- Health, Toxicology and Mutagenesis top 5%
- Small Animals top 2%
- Biomedical Engineering
- Co-authors
- Micheline Kirsch‐VoldersDominique LisonPhilippe VanparysAnn De SmedtMarlies De BoeckBart De WeverNathalie AlépéeAzeddine Elhajouji
- Topics
- Carcinogens and Genotoxicity Assessment (10 papers)Effects and risks of endocrine disrupting chemicals (5 papers)Animal testing and alternatives (5 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Freddy Van Goethem
28 papers receiving 898 citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 296
- Molecular Biology 276
- Health, Toxicology and Mutagenesis 203
- Small Animals 191
- Biomedical Engineering 129
Countries citing papers authored by Freddy Van Goethem
This map shows the geographic impact of Freddy Van Goethem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freddy Van Goethem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freddy Van Goethem more than expected).
Fields of papers citing papers by Freddy Van Goethem
This network shows the impact of papers produced by Freddy Van Goethem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freddy Van Goethem. The network helps show where Freddy Van Goethem may publish in the future.
Co-authorship network of co-authors of Freddy Van Goethem
This figure shows the co-authorship network connecting the top 25 collaborators of Freddy Van Goethem. A scholar is included among the top collaborators of Freddy Van Goethem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Freddy Van Goethem. Freddy Van Goethem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 13 | |
| 11 | 46 | |
| 12 | 25 | |
| 13 | 33 | |
| 14 | 76 | |
| 15 | 24 | |
| 16 | 94 | |
| 17 | 168 | |
| 18 | 26 | |
| 19 | 16 | |
| 20 | 1 |
About Freddy Van Goethem
Freddy Van Goethem is a scholar working on Cancer Research, Pharmacology and Small Animals, having authored 31 papers that have together received 939 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Animal testing and alternatives (5 papers). The work is most often cited by research in Small Animals (191 citations), Cancer Research (296 citations) and Chemical Health and Safety (10 citations). Freddy Van Goethem has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Micheline Kirsch‐Volders, Dominique Lison, Philippe Vanparys, Ann De Smedt, Marlies De Boeck, Bart De Wever, Nathalie Alépée, Azeddine Elhajouji, Steven M. Bryce and Svetlana L. Avlasevich. Their work appears in journals such as Nature Reviews Drug Discovery, Frontiers in Microbiology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.